Lipogems Company
Lipogems’ vision is to bring responsible, effective medical technologies to physicians and patients. Lipogems strives to provide physicians and patients with fatty tissue solutions to help maintain or restore patient lifestyles and improve quality of life and recovery times. In addition, these solutions may offer another option to those who may not want or are not candidates for major invasive surgery. Lipogems has developed and patented a disposable sterile device (CE Marked Class IIa) for close-circuit, single-step processing of lipoaspirates. In the United States, the Lipogems system is 510(k) cleared and is indicated for the harvest, concentration, and transfer of autologous adipose tissue. The system meets new FDA guidelines for minimal manipulation and is intended for homologous use.
Technology:
Autologous Stem Cells for Face Skin Rejuvenation
Industry:
Cosmeceuticals
Headquarters:
USA
Founded Date:
1992
Employees Number:
2-10
Register and Claim Ownership